Feb 7th 2023 - Mar 21st 2023
“Statistically significant improvements in lung fu... See more
there could be a cure/preventative for breast cancer out there
Feb 7th 2023 - Mar 21st 2023
In addition to NASH, Rencofilstat appears to be e... See more
but the Liver Cancer (HCC) indication and ability ... See more
The Motley Fool Stock Advisor has a track record that speaks for itself, with average recommendations that have returned over 542%*. Act now so you can start investing smarter, not harder.
*As of October 2023$79 is an introductory price for new members only. 60% discount based on the current list price of Stock Advisor of $199/year. Membership will renew annually at the then current list price.Feb 7th 2023 - Mar 21st 2023
$TGTX MOST CONVENIENT- 50% faster infusion SAFE... See more
INFUSION TIME 3.NO BREAST CANCER ISSUES 4.
“Statistically significant improvements in lung function, symptoms and quality of life 36% reduction in rate of exacerbations over 24 weeks Well tolerated safety profile over 48 weeks NDA submission planned for 1H 2023” Oh, 48 weeks! !
there could be a cure/preventative for breast cancer out there
They have a great product treating cancer with immunotherapy, peer reviewed journal
Alzheimer therapies are on the top of choices.
A drug that actually helps without any major side effects .. and breakthrough therapy. .
Better than chemo.
$AVXL The oral Anavex 2-73 therapy met the primary and secondary endpoints of the trial, with patients receiving the therapy experiencing statistically significant improvement in cognition.
In addition to NASH, Rencofilstat appears to be effective against Multiple Myeloma and Prostate Cancer.
but the Liver Cancer (HCC) indication and ability to treat alcohol liver disease alone make Rencofilstat a potential top tier therapeutic - on top of NASH.
This makes Rencofilstat a promising candidate for the treatment of a variety of diseases, including thromboembolic disorders, sepsis, and cancer.
This cancer stuff is very promising indeed,
It is regarded as an incredible drug that almost cures cancer.
“killed 70% – 90% of the cancer cells (4 different cell lines) over two days.
$TGTX MOST CONVENIENT- 50% faster infusion SAFEST - Zero Breast Cancer Risk MOST AFFORDABLE - By far If TGTX was a Big Pharma Company, the medical press would be blowing it up with praise.
INFUSION TIME 3.NO BREAST CANCER ISSUES 4.
- Lowest ARR rate, no black box label, reduced brain lesions, and no reports of breast cancer.
Lowest ARR rate, no black box warning label, reduced brain lesions, and no reports of breast cancer (there are reports of breast cancer with other MS treatments, and 75% of people with MS are women).
$TGTX "4 Stories of Living with Multiple Sclerosis" Briumvi, the best and most affordable, 1HR infusion, no black box label warning, and no warning or report of causing breast cancer.
No breast cancer risk.
Major upgrade for patients and infusion centers -No major health threats like breast cancer or sever liver damage like main competition
$TGTX possibly the best therapy available for MS patients that exists today!
MS is 3 times more common in women and there were no reports of breast cancer compared to the competition!
